NELL2-cdc42 signaling regulates BAF complexes and Ewing sarcoma cell growth

Panneerselvam Jayabal1, Fuchun Zhou1, Xiufen Lei1

  • 1Greehey Children's Cancer Research Institute, The University of Texas Health Science Center, San Antonio, TX 78229, USA.

Cell Reports
|July 7, 2021
PubMed

Insights

Ewing sarcoma cells rely on NELL2 signaling, which inhibits cdc42 and boosts BAF complexes and EWS-FLI1. This pathway regulates chromatin remodeling and cancer cell proliferation.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • BAF chromatin remodeling complexes are crucial in chromatin regulation and cancer.
  • Ewing sarcoma is a pediatric cancer driven by the EWS-FLI1 fusion gene.

Purpose of the Study:

  • To investigate the role of NELL2 signaling in Ewing sarcoma.
  • To elucidate the regulatory mechanisms of BAF complexes in Ewing sarcoma.

Main Methods:

  • Analysis of NELL2 signaling pathway components in Ewing sarcoma cells.
  • Investigating the interaction between NELL2, Robo3, cdc42, and BAF complexes.
  • Identifying distinct Ewing sarcoma cell populations based on NELL2, CD133, and EWS-FLI1 expression.

Main Results:

  • Ewing sarcoma cells are dependent on NELL2 autocrine signaling via Robo3.
  • NELL2 signaling inhibits cdc42, upregulating BAF complexes and EWS-FLI1 transcription.
  • cdc42 acts as a negative regulator of BAF complexes.
  • Identified NELL2highCD133highEWS-FLI1high and NELL2lowCD133lowEWS-FLI1low Ewing sarcoma populations.
  • NELL2, CD133, and EWS-FLI1 positively regulate each other, enhancing BAF complexes and proliferation.

Conclusions:

  • A novel signaling pathway involving NELL2, cdc42, and BAF complexes regulates Ewing sarcoma progression.
  • This pathway represents a potential therapeutic target for Ewing sarcoma.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.4K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K